Multimedia
Conference Coverage
Creating CAR T-cell therapies for T-cell malignancies
NEWPORT BEACH, CALIF. – Dr. John F. DiPersio discusses preclinical research testing CAR T-cell therapies in T-cell malignancies.
Video
Gilteritinib prolonged survival in FLT3-mutated AML
Patients with acute myeloid leukemia and FLT3-activating mutations are at increased risk for early relapse and poor overall survival.
Conference Coverage
Preclinical findings highlight value of Lynch syndrome for cancer vaccine development
ATLANTA – Lynch syndrome is serving as a platform for the development of immunoprevention cancer vaccines.
Conference Coverage
Novel chemo/PARP inhibitor strategy promising for advanced pancreatic cancer
ATLANTA – Investigators are treating patients with advanced pancreatic cancer and homologous recombination deficiencies with a novel strategy of...
Conference Coverage
UNITY-NHL: Interim findings show activity, tolerability of umbralisib for R/R MZL
ATLANTA – The phosphoinositide 3-kinase delta inhibitor is active as a single-agent therapy in patients with relapsed or refractory marginal zone...
Conference Coverage
Genetic variant increases stroke risk in childhood cancer survivors
ATLANTA - Dr. Yadav Sapkota of St. Jude Children's Research Hospital discusses the identification of a genetic variant that is strongly associated...
Conference Coverage
CAR T cells target HER2 expression in advanced sarcomas
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...
Audio
Treating lymphoma in patients with HIV
Dr. Stefan Barta joins Dr. David Henry to discuss the types of lymphoma common in patients with HIV and the best ways to diagnose and treat these...
Audio
Anticoagulation in cancer
Dr. Alok Khorana joins Dr. David Henry to discuss the CASSINI trial and the role for direct oral anticoagulants in cancer.
Audio
KATHERINE trial and breast cancer
Dr. Charles E. Geyer joins Dr. Jame Abraham to discuss practice-changing breast cancer research.
